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IN VITRO PROPAGATION AND HOMING OF LIVER-DERIVED 
DENDRITIC CELL PROGENITORS TO LYMPHOID TISSUES OF 
ALLOGENEIC RECIPIENTS 
IMPLICATIONS FOR TilE ESTABLISHMENT .-\""l'D MAINTENANCE OF DONOH CELL ClIIMERISM FOLLOWI:-\C LIVER 
TRANSPLANTATION 12 
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Dendritic cell (DC) progenitors were propagated in 
liquid culture from nonparenchymal cells resident in 
normal mouse (BI0.BR: H_2k. I-E+) liver in response to 
granulocyte-macrophage colony stimulating factor 
(GM-CSF), The liver-derived DC progenitors were 
MHC class n-/d'm and did not express counter recep-
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tors for CTLA-4. a structural homologue of the T cell 
activation molecule CD28. Following subcutaneous or 
intravenous injection. these liver-derived cells mi-
brrated to T cell-dependent areas of lymph nodes and 
spleen of unmodified. allogeneic (BI0; H.2h ; I-E-) re-
cipients. where they were identified 1-5 days. and i 
and 2 months after injection by their strong sunaet· 
expression of donor MHC class II <I_Ek) and their den 
dritic morphology. Maximal numbers of liver-derivl'( 
DC in the spleen were recorded 5 days after injection. 
Both clusters of strongly donor MHC class 11+ eells-
and (more rarely' dividing cells-could also be identi· 
fied. suggestinl( cell replication in situ. Using the same 
techniques employed to generate DC prol(enitors from 
normal liver. GM-CSF-stimulated cells were propa-
gated for 10 days from the bone marrow and spleen of 
non immunosuppressed mice sacrificed 14 days after 
orthotopic liver transplantation (BI0;H·2b - C3H;H-
21<,. Immunocytochemical staininl( for recipient and 
donor MHC cla .. II phenotype revealed the growth 
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both of host cells with DC characteristics. and of cells 
expressing donor alloantigens I I-A b). These results are 
consistent with the growth. in response to GM-CSF. of 
donor-derived DC from progenitors seeded from the 
liver allograft to recipient lymphoid tissue. The func-
tional activity of the progenitors of chimeric DC and 
the possible role of these cells in the establishment 
and maintenance of donor-specific tolerance following 
liver transplantation remain to be determined. 
It is now thought that the comparative ease of~acceptance" 
of different transplanted organs may reflect their endowment 
with "passenger" leukocytes (1. 21. Of these. bone marrow-
derived dendritic cells mC)* are thought to be the most 
important. because of their capacity both to present antigens 
and to deliver activation signals to T cells (3--5). The liver. 
which is the most tolerogenic whole organ (2, 6-10). has a 
comparatively heavy content of DC (11-15), and can be trans-
planted across major histocompatibility barriers in most 
mouse strain combinations. without immunosuppression (21. 
Further insight into the tolerogemcity of the liver may 
emerge from studies of the functIOnal properties of liver DC 
\\ Illch, to date, have been the subject of very few tnvestiga-
tlOns. 
Recently, we have shown that DC with potent allostimu-
latory activity for naive T cells can be isolated from nonnal 
mouse liver (16). In addition. we have succeeded in propa-
gating DC progenitors from liver non-parenchymal cells 
I NPC) In response to the cytokine h'Tanulocyte-macrophage 
colony-stimulating factor (GM-CSF) I In Although these 
nonadherent. low-huovant-denslty cells express DC-restricted 
surface phenotvpic markers. thev are aVldlv phagocytic I a 
characteristic of immature DCl and are resistant to the in-
ductIOn bv cytokines of either cell surface major histocompat-
Ihilitv complex \ ~IHC) class II antigen pxpression or allo-
llmulatorv actlvlt~'. 
.\n Important functIOn of DC lineage cells is their capaclt\, 
.\hhn'vlatlOns: ,\I'c. ,llItll!en-prl,,.t'nllnl! n·11; Dt'. dendntlc n'I1s: 
\ ;;\1-( ·SF. ;.:ranuiocvte-macrophul!c (1JIol1v-'lImulatml! lactor: b. 
Immune-associated anlll!cn; mAb. IllOnocional antlbodv; ;\tIlC. malor 
111stocolllpaubtlitv complex; NPC. I\onparl'nchvmal ceil; HT. room 
il'mperatllrt'. 
!-"i(;t·H': 1. (·.,tocentnfu\,(e prl'puratlon ,howm\.l Cl'lIS rt'leused from 
(;:'I-CSF-slImuiated liver cell aL!I.,'rl'l(atl'S ,day llli. which l'xhlblt 
,rn'l.,'Ularl\· shaped. l'l'centnC nuclei. abst'nce 01 promment ,.,<ranules. 
.1Ila dlstmn cvtopiasmlc proceOises II • .'lentSa: . "O(h 
T.\BLE 1. Immunophenotypic characteristics of nonadherent. G:\I-
CSF stimulated mouse liver-derived DC progemtors harvested 
rrom liquid cultures: comparison with GM-CSF stimulated spleen-
derived DC 
CI: 
" 
Antigen (mAbl 
Leukocyte-common Ag 
CD45 
CD45RA;B220 
MHC Class II: I_Ek.d.p.r 
DC-restricted 
Lymphoid DC (3301) 
Interdigitating cell (NLDC 145) 
Myeloid IprimanlyJ macrophage 
(F4I80) 
Lymphoid (primarily) 
CD3e 
Heat-stable antigen (Jl1Dl 
NK cells: NKl.l 
ReceptorS! adhesi ns 
CD32, FcyRlI 
CDllb. :\1AC-1a umt; C3biR 
CDllc. pISO/90 (N41HI 
CDH. PJnl-l 
CD54. ICAM-l 
CTLA-4 counter-receptors 
CD25, p55: IL-2R 
., Not determined. 
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FI!;UH~ :!. Absence of allostlmulatorv actiVIt\' IIf y-irradiated. (;;'1-
('SF-slImulated. l3lO.l3R lIlouse 11\"I'r-dprtvl'd DC progemtors I i::J1 
!Ism\,( n3lve. l310 II-E I ,piCniC T celis as rl'sponders. The nonadhcr-
('nt, low-buovant-denslty l'l'11s Wl're harvl'~l('d from lO-day GM-('SF· 
,timulated culturc~ and set up at various conc('ntratlons. With 4 A 10' 
responder T cells. ('ultun's wl'n' mallltallwJ for 7:! hr: 1·IHITdR was 
.Iaded III hr la'tllre h:trvl'sttn~. TIlt' .\ILH-,lImuiatory actlVltv Ilf 
freshlv-isolated allo\.lent'lc ,B IOBf{1 liVl'r :-.'1'(' 101 and spleen cl·ils 
! ,]1 and of SVnl!l'nl'll' I Illll: I' 'II splt'en CL'lls IS also shown. The resuits 
.Ire t'xprl'sscd as IIwan counts pt'r mmlltl' ,,·pml : 1 SO and art' 
n'pre~enlatl\,l" of;1 .:o;('paralt' l'xpenmL'nls. 
to llli/-,'Tate or ··home· to secondarv I,,'mphold tissue 118. IY I 
and theretn to prL'sem nnll!!;cn to T cells. The nature and thl' 
dlecttveness of thiS l'L'llular IntcraCllon may determtne the 
\ mmunol.!'emcltv/tolerol.!'emcltv of t,rraft alloantlgens. In thiS 
"tudy. WI' have l'xamtned the In VIVO mli.,rrntory actlvitv. !:ltc. 
;lOd /-,'Towth potential of mouse liver-denved DC progemtors. 
\tATJ::RIAUi 1\.~U :.tJ::TlIODS 
. \I/Imai.~ . . \dult Ii -I:! wl't'k old male B IO.BR (H-2". I-E ·1, C5iBr.., 
IOSnJ lillO. I!-:!". I-A· I .1IId C:Ut-HeJ 'l'3H. 11-2", I-E·' mIce wt're 
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purchased from The Jackson Laboratory. Bar Harbor. ~lE. They 
were maintained in the specific pathogen-free facility of the Univer· 
sity of Pittsburgh Medical Center. 
IsolatIOn o{ non parenchymal cells (rom ILl·er. Nonparenchvrnal 
cells (NPC) were isolated from normal BIOBR mouse liver followmg 
in situ perfusion. digestIOn in collagenase solution. and Percoll cen-
trifu~atlon. as descnbed in detail elsewhere un Hepatocyte con-
taIIllllatlon was consistently <5%. Fresh spleen cell populations 
were prepared using the same protocol. to control for possible en-
zyme-mediated effects. 
Culture at'liver. spleen. or bone marrow-derived DC lineage cells 
with GM·CSF. Liver NPC or spleen cells. or bone marrow cells 
isolated uSing conventional procedures \2.5X lOb) were placed in 
wells of 24-well plates containing 2 ml of RPMI-1640 complete me-
dium (Gibco. Grand Island. NY) supplemented with lOlk v/v fetal calf 
serum and 0.4 nglml recombinant mouse GM·CSF <R&D Systems. 
Minneapolis. MN). Nonadherent, low buoyant density DC-lineage 
cells released from developing clusters were propagated as descnbed 
recently ( 17). usmg a modification of the method of Inaba et al. (20). 
The cells were harvested routinely for study after 7-10 days of 
culture. In some expenments. GM-CSF·stlmulated liver·denved 
populations were depleted of all la-rich cells by complement-depen-
dent lvsls. usmg mouse anti-I-Ek monoclonal antibody I rnAb) 
(PharMingen. ::ian Diego, CAl and low-toXIcity rabbit complement 
(Accurate Chemical & Scientific. Westbury. NY). la' cell depletIOn 
was confirmed by both flow cytometry and immunocytochemistry. 
Flow c.vtometrlc analysis. Immunophenotyplc analysis of liver or 
spleen·derived cells was performed by either direct or mdirect im-
munotluorescence stainmg as described elsewhere. uSing an exten· 
sive panel of rnAbs !l71. These included antibodies directed against 
mouse lymphOid. myeloid and DC-restncted markers 13301. TIB227; 
ATCC. NLOC-145: and COllc. N41S; kmdly prOVided by Or. R.M. 
Steinman. Rockefeller University, New York. NY). In addition. 
counter-receptors of CTLA-4 (a structural homolo!tIJe of C02S1 
(CTLA·.tCRl. which include CDSO family members 187IBBll and 
B701B7-:l. were Identified using the CTLA-.tlg fusion protein (kindly 
prOVided by Dr. I'.S. Lmsley, Bristol Mvers SqUibb Pharmaceutical 
Rl'search Institute. Seattle. WAI (211. with human 19 "Sigma) as a 
n"~atlve control. Flow cvtometric analYSIS was performed usmg a 
F \( 'STAH flow cytometer I Becton Dickmson. ::ian Jose. CAl. and five 
t IlI,usand t'vpnts wpre acquired for each sample. 
.\flxed /cuiwcvl" culture ... To test the Immunogemcltv of cultured 
liver or splepn·denVl'd cells. one-way mixed leukocvte cultures were 
pertc)rmed 1!1 Y6-wp11. round·bottomed microculture plates With van· 
able numbers of GM·CSF·stlmulated. 'Y'lrradlated \:l0 Gv I allo~enelc 
I B 10.BHI or svngenelc I B 101 liver or spleen cells as stimulators. B10 
:ipleen n~lls 14( 10'-' per well) ennched for T cells by pa.:lsa~e (1 hr, 
through a nvlon wool column were used as responders. Cultures were 
mamtal!1l'd for 72 hr: I'HITdR wall added III hr belore harvesting 
and the extent of DNA syntheSIS determmed bv liqUid scmtlilation 
counting. 
ncntintlc <"iI h"mlnl!. :-.Iondepleted or la·depleted cultured 
l! 10.IlH livl'r· or spleen·denved cells were washed 10 Hanks' hal· 
,need salt ,;olUtlon and mlected s.c. < lor 2.5" 10" cells 10 flO ",II into 
fle hmd ti,otpad or LV ,10" in <!OO /.Lli vIa the lateral tnt I vl'm of 
"rmLlI B 10 mice. Une dav to :.! months later. groups of J ammnls 
were killed and the draining popliteal lymph node (where appropn-
ate'. thymus. and spleen were removed. embedded in Tissue-Tek 
IO.C.T. Compound. Miles. Elkhart. IN) and frozen at -70°C. Cryo-
stat sections (5 /Lml were air-dried at room temperature (RTl over-
night. then stored at -70°C until used. 
Immunocytochemistry. Cryostat sections <equilibrated at RT) or 
cytocentnfuge preparations of cultured cells were fixed in acetone. 
then stained for donor MHC class II using biotinylated mouse IgG2. 
anti-mouse I_Ek.d.p.r or anti I_Ab mAbs <PharMingenl as appropriate. 
in an avidin-biotin-peroxidase complex (ABC) staining procedure. 
Controls included sections or cytospin preparations of normal donor 
or recipient strain tissues or cells. The incidence of donor MHC class 
II· cells in sections was determined by the mean number of positive 
cells per 100 high power fields (hpO. 
Liver transplantatLOn. Orthotopic liver transplantation (OLTx) 
was performed in a mouse strain combination (BI0 to C3H; MHC 
class 1. II and mHC disparities) with a high acceptance rate, using 
techniques described previously in detail (22), wah minor modifica-
tions. No immunosuppressive therapy was used. The animals were 
killed 14 days after OLTx (three animals per group I. 
RESULTS 
Growth and immunophenotype of liver DC progenitors. 
Approximately 2.5 X 10° low-density nonadherent cells with 
typical dendritic shape and other morphological features of 
DC (Fig. 1) could be harvested per liver after 7-10 days of 
culture in GM-CSF. Flow cytometric analysis (summarized 
in Table 1) con finned that these cells expressed surface an-
tigens associated with mouse DC, including CD45 (leukocyte-
common antigen), heat-stable antigen, CD54 (lCAM-ll, 
CDllb (MAC-n and CD44 (nonpolymorphic detenninant of 
Pgp.l glycoprotein). In addition, staining of weak-to-moder-
ate intensity was observed for the DC-restrIcted markers 
NLDC-145 (interdigitating cells). 33D1 and N418 and for 
F4/80 and CD32 lFcyRIIl. The Intensity of expression of 
these markers on GM-CSF-stimulated spleen cells was 
similar, except that CD32 and CDllb were reduced and 
:l3D1 and NLDC 145 were slightly more and less intense. 
respectively, compared with the liver-derIved cells. In con-
trast to the spleen cell progeny. which were MHC class 
IIhr'lCht and pmlltive for CTLA-4CR. the liver-derived. 
GM-CSF-stimulated cells were MHC class I1 d <m and did not 
express detectable CTLA-4CR. 
Allostlmulator.' activity or GM·CSF·propa~ated liver· 
derwcd celis. Compared With freshly isolated BlO.BR liver 
NPC or spleen cells, the GM-CSF-stlmulated liver DC pro-
genitors failed to induce proliferation In naive. allogeneIc 
I B 10: I-E ) splenic T cell populations (Fig. ~ I. Similar obser-
vations were made whether nondepleted or la-depleted cell 
populations were tested. GM-CSF·stlmulated spleen-derived 
~C. however. which expressed much higher levels of surface 
:'IHC class II antIgen and also CTLA-4CR. were efficient 
FI(;CHE :l. 'il- h I. Hamtn\,( abllitv ofG;\t·CSF·~t1mulated B IO.BR liver-denvl'd cell:! DC progemtors relea:;ed tn culture tram proliferatmg cell 
;lg!tl'ef.!llle~ ,harVl'~ted on day 101. The ceils I:.!.S" 10'" wl're tnlected s,c. ,day III IOta one hmd footpad of B10 (J·E I rl'Clp\l~nts and detected 
by Immunohlstochemlstrv, I·E' ) m crvostat sections of drammg lymph node:!. ~Illeen. or thvmus 1 day to L months Inter. The sections were 
'tamed. ustng the ABC peroXidase procedure. With donor·specuic mouse !lntl·l·r:- rnAb. together WIth appropnate controls. lal day 1. spleen: 
.1 strongly donor MHC ciasll U-posltlve cell 10 the T·dependent area of recIpient spleen. dOlle to on artenole I arrow I; I bl. day 1. lymph node: 
:1 slnlde pOSitive ceil tn the :lubcapsular space and some additional structure:! IUrroWli1 that may represent ltghtly pOSItive celis: tC) day 1. 
thvrnus: a positiVe cell tn the medulla; Id' dav ii. spleen; seyeralstronlfly pOSItive cdl:! With dendnuc morpholo~ In T·dependent area near 
.in artenole: Ie' dav 5. spleen: Isolated donor class 1I" cells with dendnuc morphololfY lind an all:l(t't!llBte 01 similar cells. each of which 
,'''presses donor phenotype: In 2 weeks and \11:1 :.! months. spleen: showlnll: po:!ltlve celill and I hI day 4. spleen; a dividing donor dan 11· cell 
.'-- .-.--•. ~- ~. r""' .. nl .. tOfC>d_ liver- e veri OC rogenltoMllnll x 10001. 
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FIGURE 4, ~!ean number:: 1 SD of donor MHC class II + cells with 
dendritic morphology observed in spleen per 100 high-power fields 
I hpf) 1-60 days after s.c. footpad injectIOn of 2.5x 105 GM-CSF-
oitlmulated. liver-derived DC progemtors. 
inducers of pnmary allogeneic T cell responses (data not 
shown). 
In vivo mIgration of liver-derived developing DC. We 
wlshed to determine the migratory ability of the liver-derived 
DC progenitors after their local (s.c.! or i.v. injection (in the 
latter instance to mimic possible consequences of liver trans-
plantatIOn!. As shown In Figure 3. at least some of the Iiver-
derived cells homed after footpad or I. v. injection almost 
exclusively to the T cell areas of recipients' spleens. where 
they were Identified by expressIOn of donor MHC class II 
II_Ek) in close proximity to artenoles. Similar observations 
were made In the draining popliteal lymph nodes of footpad-
Injected mIce: occaSIOnal I-E' cells were also observed in the 
thvmlc medulla. Manv of these chimenc cells exhibited dis-
I I~ct dendntlc morphology. Donor l\IHC dass II· (I_Ek +) 
cells were tirst observed in Ivmph node or spleen :.!4 hr after 
inJectIOn. Interestingly, structures resembling weakly donor 
:\IHC dass II - cells were also observed in lymph nodes at 24 
hr (Fig. 3 L \\Thether these were maturing donor-derived cells 
IIr reCIpIent cells that had taken up shed donor MHC class II 
pep tides was not determined. In the spleen. maximal num-
bers of I_E k' cells were found on dav 5 (Fig. 4). Thereafter, 
numbers declined, but I-EK - cells were still detected in T cell 
:lreas :.! months after the injection of liver-derived DC pro-
genitors. In addition to Isolated cells. aJ.,(gregates (Fig. 3e) and 
.dso rare diVIding cells (Fig. Jh) were found WIthin the first 5 
days after InJectlOn. To address the question of whether up-
regulatIon of :\tHC class II expresslOn or selective mIgratIOn 
.11' the small proportion of class II - cells had occurred in VIVO. 
[a' cells were removed before InJecLlon of the cultured cells. 
~im!lar observations were made whether nondepleted or la-
depleted. liver-derived cells were Injected: after s.c. injection. 
Ihe mean number of posItive cells per 100 high-power tields 
In the spleen at 5 days was 15.8=.8.9 and 15.3::9.2 per toO 
hfp. respectively. 
(;rowth of cells e:cpressln~ donor phenotype (rom hone 
marrow and spleen o"lit'er·(ltlo~ra,ted mIce. We next tested 
whether. uSing the same techmque as was employed to prop-
agate DC lineage cells from normal mouse liver. GM-CSF 
stimulated cells of donor phenotype could be propagated from I 
the bone marrow or spleen of mice killed 14 days after allo-
geneic orthotopic liver transplantation (BI0 - C3H). Flow 
cytometric analysis of donor and recipient MHC class I (> II 
surface antigen expression in freshly isolated suspension;; If 
bone marrow or spleen cells revealed a low incidence ( <:'i I 
of donor (H_2h .. 1 cells, compared with 89% and 97% recipient 
cells (H-2k .. 1, respectively. Ten days after the initiation of 
GM-CSF-stimulated cultures, in which selective enrichment 
for cells with DC characteristics was performed, a minor 
population of donor MHC class II+ cells could readilv he 
identified both in the bone marrow and spleen cell popula. 
tions (Fig. 5). Cells were also propagated for 10 days from the 
spleens of normal BI0 (donor strain) and C3H (recipient 
strain) animals and stained both for I_Ab and I_Ek, Wlth 
appropriate Ig isotype controls. No mAb crossreactivity was 
observed. These findings are therefore consistent with the ex 
vivo propagation of donor liver-derived DC from progenitor,;, 
or even stem celis, seeded in the lymphoid tissue of the orga:l 
allograft recipients. 
DISCUSSION 
Unlike GM-CSF-stimulated DC propagated from normal 
mouse blood (201, bone marrow (25), or spleen, the majority of 
GM-CSF-stimulated cells with DC characteristics derived 
from liver NPC express little or no cell surface MHC class II 
antigen. Furthermore, as we have shown here, the liver· 
derived DC progenitors fail to stImulate unprimed alloreac-
tive T cells-i n contrast to freshly isolated spleen cells Of 
hepatic NPC. a finding in keeping with the very low intenSity 
ofMHC class II and CTLA-4CR detected on their surface. A~ 
shown preVIOusly (171, these cells also exhibit aVld phago· 
cytic activity-a property of immature DC. They can h011 
ever. be induced to mature in vItro (confirmmg their [) 
lineage) by exposure for several days to the extracelluL 
matnx protein type-l collagen 1/7) that is spaclallv assocI 
ated WIth MHC class II' DC in the portal triads Within 
normal liver. Recently, there has been increased speculation 
that such "immature" DC or DC progemtors present in non-
lymphoid organs may constitute tolerogenic progemtors ot 
chimenc cells in recipients of organ allografts U, 17.231. 
A speCialized property of bone marrow-derived DC is their 
capacity to migrate in vivo to T-dependent areas of periph-
eral lymphoid tissues (18, 19) wherem they present antigen 
to T cells. In this study. we assessed the hommg ability ot 
CM-CSF-stlmulated. developing, liver-derived DC (Jow I-E" 
l'xpreSSlOn or la followmg complement-mediated IVSISI that 
were Injected eIther locallv or systemIcally (to mimiC posslbl( 
~equelae of liver transplantatIOn I Into allogeneIc B 10 !I-E 
reCipients. \\Then the reCipients were killed after 1 to 5 da\',-
at least some of the mJected cells were found to have mi' 
h'Tated to T cell areas of the drnlmng lymph node latter locai 
injection I and spleen. In these sites. they were easIly identI-
lied as donor by their strong cell surface staining for MHC 
dass II <I_EKl. Sigmticantly, the lIver-derived cells or theIr 
progeny perSIsted in the spleen much longer (for at least :.! 
months I than those donor-denved DC descnbed in the same 
llssue up to only 4 days after cardiac transplantation In 
unmodified mIce that rejected their grafts within 8-12 davs 
1181. This may. of course. retlect both qualitative and quan-
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FIGURE 5. la). donor MHC class II· II-AU') and (b). reCIpient MHC class II· (I-Ek+) cells with dendritic morphology In lO-day GM-CSF-
supplemented cultures of bone marrow-denved cells isolated from a C3H (H-2k) mouse reCIpient of a B10 (H-2") liver allograft. 14 days after 
transplantatIOn \ ,1000L lei. mouse IgG isotype control (,,400l. No staming ofGM-CSF-stimulated C3H or B10 spleen cells (derived from 
normal mlcel With anti-I-A" or antI-I-E'. respectIvely. was observed (data nut shownl. 
tl! ative difTerences In the migratory DC populatIons denved 
fr.ltn Itv!'r and heart. Either wav. the persistence of injected 
clllmerll: (!'Ils of DC lineage within lvmphoid tissue of un-
modified allog'enelc reCIpIents IS consIstent wllh the failure of 
these arumals to reJect liver aliOI-.'Talts Ill. It is also III <lh'Tee-
ment With the survIval of donor-derived leukocvtes.lncluding 
DC. WIthin the central lymphOId tissue of unmodified murine 
liver allol-,rraft reCIpients for up to one year posttransplant (2l. 
Donor chimeriC leukocvtes have slmliarly been observed in 
spleens of liver-allografted rats up to ;JOO days posttrans-
plant (:2/1. 
The comparatlvelv long survival and apparent maturation 
of liver DC prog'emtors homing to T cell-dependent areas of 
allogene\<: Ivmphold tissue IS consIstent With the contentIOn 
I:.'. :2·11 that the destination of donor-derIved leukocvtes. ml-
,~·':ltmg alter whole organ transplantation. IS lineage-specltic. 
: dowlI1l.!' routes ';lImlar to those taken bv ~vngenelc cells of 
tile same It neages. After transplantation of the h vcr or other 
Ilrgans. Immature cells of DC linea!!e mav underl.!'o 1!1 VIVO 
ditTerentlatiorvmaturatlon 1 as shown here In terms of the 
llpre~'UlatlOn of cell surface MHC class II expressIOn I under 
the rl'~'Ulatorv tnt1uence of endogenous t;~I-CSF :lnd other 
cytoklnes. such as tumor necrosIs factor-" and IL--t. 111 an In 
VIVO recapitulation of the results of in vitro maturation 125-
2il. The kinetics of this maturation process are likely to be 
intluenced by the extent of host ImmunosuppreSSIOn. ;,11-
thou~h the general pat.hwavs of donor cell mIgration and 
differentiation have been shown to be much the same In 
liver-aliografted rats treated WIth FK506 f2.Jl. The implica-
t ions of the r:lpid eh'Tess from the liver 1 a potential hema-
tolymphoid org-an 1281l of progenitor DC With replicative 
capacity. exhibiting low ceil surface MHC class II expressIOn 
and low T cell-stimulating actiVIty. are conSiderable. The 
implications of these findings are underscored both by the 
I!'ngthy persistence of these cells in nOlllmmunosuppressed 
hosts and by our capacity to propagate cl'lls of donor pheno-
tvpe In vitro from the l.vmphoid tissue of liver allograft re-
CIpients. This latter ohservation is consistent with the detec-
tam of presumptive proliferating 1 1O-15 r ; I donor cells within 
t he spleens of liver-ailogratted rats seVl'ral davs posttrans-
plant 1:!.Jl. Taken together. these tinding:; sUl.!'gest a mecha-
rl\:;tic basis for cytokine-driven perpetuation of donor leuko-
cvte chimerism in recIpients of liver and other organ grafts. 
Thev also prOVIde support filr the therapeutic strategy of 
:IUh'1Tlentatlon of natural chimerism In human allograft re-
CIpients currentlv heing evaluated at thi:; medical center t.:!91. 
The pOSSIble functIOnal role of chImeriC cells of DC lineage 
,lnd their progeny In organ allOh'Taft acceptance remams to be 
determll1ed. The eXIstence however. of subpopulations of mu-
nne Oc With a veto functIOn I inactivation 01 T helper cells or 
L!'tOtoxlC T cell precursors, hali been proposed I:JUJ. In addl-
t Ion. ~IHC dass Hoom :lllogeneic donor bone marrow cells. 
"hown to exhibit vela cell activity. have been post.ulated to be 
I mmature DC (,"] 11. Althoul{h the precise oaSIs of DC-T cell 
I 
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interactions that might lead to tolerance induction is uncer-
tain. it is most likely to depend on the relative affinity or 
avidity I compared \\;th "i mmunizing" antigen-presenting 
cells [APC]) of donor DC-T cell receptor interactions and on 
the expressIOn on the former cells of critical adhesins and 
costimulatory molecules. such as members of the CD80 <B7-
11B7-2l family. These aspects of developing liver and bone 
marrow-derived DC both in vitro and in vivo are under 
further investigation in our laboratory. 
Following local or systemic injection into nonimmunosup-
pressed allogeneic recipients. liver-derived DC progenitors 
propagated in vitro homed to T-dependent areas of lymph 
nodes and spleen. They were detected by the expression of 
donor MHC class II antigen and they persisted for at least 2 
months in the spleen. where rare dividing cells identified as 
donor were also detected. Using the same techniques em-
ployed to propagate DC progenitors from normal liver, both 
bone marrow and spleen cells obtained from liver allograft 
recipients 14 days after transplantation were cultured for 10 
days in GM·CSF. This resulted in the propagation of recipi-
ent-derived cells and of cells expressing donor MHC class II 
antigens. suggesting the growth of donor cells from precur-
~ors seeded to host lymphoid tissue. These findings provide 
insight into the establishment and perpetuation of donor 
IAPC) cell chimerism following transplantation of the liver 
and possibly other organs. 
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SOLUBLE CTLA4Ig MODIFIES PARAMETERS OF ACUTE 
INFLAMMATION IN RAT LUNG ALLOGRAFT REJECTION 
WITHOUT ALTERING LYMPHOCYTIC INFILTRATION OR 
TRANSCRIPTION OF KEY CYTOKINES 1 
YUJI MATSUMURA.~ XIO-J[NG ZUO,J JOHN PREHN,J PETER S. LINSLEY,4 ALBERTO MARCHEVSKY,5 
ROBERT M. KAsS,2 JACK M. MATLOFF,2 AND STANLEY C. JORDAN3•6 
Department of CardiothoraCic Surgery. Pediatrics. and PatholoRY. Cedars-Sinai Medical Center, Los An!?eles. California; 
and Bristol-M_vers SqUIbb Pharmaceutical Research Institute. Seattle. Washington 
The efficacy of CTLA41g in blocking immune activa-
tion and allograft rejection (AR) was tested in an ag-
gressive and rapid model of rat lung AR (Brown Nor-
way [BNI - Lewis (LEWl). CTLA41g is a recombinant 
soluble protein that binds with high affinity to rat 
B7IBBl and other surface molecules on APCs. subse-
quently blocking the binding of B7IBBI to CD28/ 
CTLA4 on T cells. This interrupts the costimulatory 
pathway critical for complete T cell activation and 
('ompletion of the AR process. Left single-lung trans-
plants were performed between BN-Lew. Five al-
lograft recipients were examined in each group. At 
transplantation, animals received 250 p.g of CTLA41g 
or 250 p.g of control Ig intraperitoneally daily until 
sacrifice. Animals were sacrificed on days 2. 4. and 7 
after transplant. Control (BN-Lew~ grafts show irre-
versible rejection by day 7. Syngeneic (Lew-Lew~ 
grafts show no AR on day 7. AR episodes were graded 
histologically (stages O-IV) and pathologic intensity of 
inflammation was graded on percentage of involve-
ment. Cytokine transcript levels were measured in 
control and CTLA4Ig-treated animals (n = 5 in each 
group I on day 7 using reverse transcriptase poly-
merase chain reaction techniques. The most profound 
.Iifferences were found on day 7 after transplant. The 
I Prl'sented at the :lOth Annual Meetm2 of the Amencan Socletv of 
Transpiant PhvslclUns. :'>lav 18-:20. 1994. Chical!o. I L. 
, Department 01 Cardlothoraclc Surl!ery. l'edars-Sinal Medical 
Center. 
I Department of Pedialncs. Cedars-Sinal ~ledlcal Center. 
I I1ristol-~lvers SqUibb Pharmaceutical Research Institute. 
" Department of Pathol0lO', Ct!dars-Smal Medical Center. 
" :'l.ddress correspondence to: Stanley C. Jordan. :'>10. Director. 
Pediatnc NephrololO' & Transplant immunolofO'. Ledars-Sinal Med-
Ical Center. Professor of Pediatncs. CCLA. Ledars-Sinal MedIcal 
Center. !l7DD Beverly Boulevard. Los Anlfeles. LA 90048. 
degree of lymphocytic infiltration was greater in the 
CTLA4Ig group (perivascular: 4±0 vs. 2.6±0.6, peri-
bronchial: 4±0 vs. 2.2±0.4. and peribronchiolar: 3.6± 
0.5 vs. 2±0.3. P<O.Ol). However. in striking contrast. 
the stage of AR (3±0 vs. 4±O, P<O.Ol). vasculitis (1±0.7 
vs. 2.6±0.6, P<0.05). hemorrhage <O.4±0.6 vs. 3.2:0.4. 
P<O.Ol). and necrosis IO±O vs. 2.4:0.5, P<0.005) were 
significantly reduced in animals treated with CTLA4Ig. 
Since CTLA41g blocks Thl cell activation in vitro. we 
compared the levels of Thl inflammatory cytokines 
IL-2. y·IFN. and TNF'a in the two models. The intra-
graft ratios (CTLA4Iglcontroll were IL·2:0.77. y-IFN: 
1.29. and TNF·a:1.33. Thus. CTLA41g did not signifi-
cantly block intragraft production ofThl cytokines on 
day 7. Transcript ratios for cytokines known to sup-
press Thl cell activation tlL-4. IL-IO. and transforming 
growth factor-tJl) in CTLA41g to control Ig were all 
about 1. which indicates no preferential expression of 
Th2 cytokines in CTLA4Ig-treated animals. Cytotoxic 
T cell serine protease and c-myc transcript levels were 
similar in both groups. Our findings suggest that: (1) 
CTLA41g exerts a profound and statistically signifi. 
cant inhibitory effect on inflammatory and cytode-
structive events in the BN- Lew allograft model on 
day 7; (2) there is no effect on lymphocytic infiltration, 
cellular proliferation. Thl. Th2 cytokine transcript 
levels. serine protease transcript levels. and c·mvc 
transcript levels: (3) the inability of CTLA41g to co~­
pletely block cellular infiltration and cvtokine tran-
scription may be related to its known d~creased effi-
cacy in rat models. possibly related to potent 
costimulatory signals that are independent of the 
CD281B7 pathway. 
Lung tr:lnsplantlltlon has become a VIable treatment for a 
\,anety of terminal lun~ diseases. and yet. rejection-acute 
and chrome-remains a senous problem. accounting for about 
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